Ryan Aschenbrener, MD
Physical Medicine & Rehabilitation · Washington, DCNPI 1649702317
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,767 of the $8,461 with a category attached, or 80.0%. It is spread thinly across 22 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,040, 2.2 times the $1,356 reported in 2021. Among physical medicine & rehabilitation clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $45.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Abbott$968
- Biotronik NRO, Inc.$961
- MML US, Inc.$906
- Medtronic$878
- Boston Scientific$685
- plus $3K from 16 others
What the payments were for
- Travel & lodging$1,69520%
- Food & beverage$6,76780%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 17 | $1,517 |
| Abbott | 17 | $968 |
| Biotronik NRO, Inc. | 17 | $961 |
| MML US, Inc. | 8 | $906 |
| Medtronic | 21 | $878 |
| Boston Scientific | 15 | $685 |
| Collegium Pharmaceutical, Inc. | 22 | $441 |
| Nalu Medical, Inc. | 5 | $332 |
| Saluda Medical Americas, Inc. | 5 | $295 |
| Scilex Pharmaceuticals Inc. | 13 | $278 |
| Bioventus LLC | 6 | $233 |
| Relievant Medsystems, Inc. | 4 | $201 |
| Virtus Pharmaceuticals LLC | 7 | $153 |
| Averitas Pharma Inc. | 6 | $131 |
| Nevro Corp. | 5 | $114 |
| Kowa Pharmaceuticals America, Inc. | 7 | $103 |
| Vertex | 3 | $74 |
| Si-bone, Inc. | 3 | $68 |
| SPR Therapeutics, Inc | 1 | $35 |
| IBSA Pharma Inc. | 2 | $35 |
| Protega Pharmaceutials Inc | 2 | $30 |
| Forte Bio-pharma LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$1,255
- ReActiv8$725
- Prospera$518
- PROCLAIM$427
- INTELLIS ADAPTIVESTIM$335
- Evoke$246
- Nalu Neurostimulation System$237
- KYPHON EXPRESS II KYPHOPAK TRAY$156
- Durolane$129
How this compares
$8,461 in reported general payments places this provider in the 95th percentile of 41 physical medicine & rehabilitation providers in District of Columbia.
See all physical medicine & rehabilitation providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 61 | $48,218 |
| ZtlidoLidocaine | 43 | $30,372 |
| Xtampza ErOxycodone Myristate | 19 | $9,704 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 206 | $6,696 |
| Buprenorphine | 18 | $3,725 |
| Pregabalin | 164 | $2,890 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $2,825 |
| Oxycodone Hcl | 148 | $1,947 |
| Celecoxib | 67 | $1,618 |
| Gabapentin | 168 | $1,614 |
| Lidocaine | 14 | $1,462 |
| Tizanidine Hcl | 97 | $940 |
| Tramadol Hcl ErTramadol Hcl | 17 | $916 |
| Baclofen | 51 | $762 |
| Diclofenac Sodium | 24 | $559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Ztlido | $278 | $30,37243 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $441 | $9,70419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 physical medicine & rehabilitation providers in District of Columbia.
Other physical medicine & rehabilitation in Washington
- Richard ZorowitzWashington$57K
- Suzanne GroahWashington$2K
- Eric WisotzkyWashington$2K
- Nikolai KhromouchkineWashington$2K
- Erika GosaiWashington$1K
- Nathan YokelWashington$1K
- Howard GilmerWashington$700
- Jasmine MalhotraWashington$670
- Michael WrotenWashington$586
- Megha MandalaywalaWashington$464
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.